Any doubts about the US Food and Drug Administration's expectations for regulated industries' compliance with its recall regulations should end as it publishes its third guidance in six months on firms' responsibilities for removing noncompliant products from the market.
The agency's voluntary recalls draft guidance includes training among it suggestions – not only training employees but also
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on HBW Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?